AR067345A1 - Uso de trombomodulina para la preparacion de un medicamento trombolitico - Google Patents

Uso de trombomodulina para la preparacion de un medicamento trombolitico

Info

Publication number
AR067345A1
AR067345A1 ARP080102791A ARP080102791A AR067345A1 AR 067345 A1 AR067345 A1 AR 067345A1 AR P080102791 A ARP080102791 A AR P080102791A AR P080102791 A ARP080102791 A AR P080102791A AR 067345 A1 AR067345 A1 AR 067345A1
Authority
AR
Argentina
Prior art keywords
thrombomodulin
preparation
thrombolitic
medicinal product
patient
Prior art date
Application number
ARP080102791A
Other languages
English (en)
Inventor
Benning Brohmann
Daniel A Lawrence
Karl-Uwe Petersen
Original Assignee
Paion Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40229136&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR067345(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP07013480A external-priority patent/EP2014296A1/en
Application filed by Paion Deutschland Gmbh filed Critical Paion Deutschland Gmbh
Publication of AR067345A1 publication Critical patent/AR067345A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/366—Thrombomodulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Uso de trombomodulina para la preparacion de un medicamento para estimular la reperfusion de un tejido u organo isquémico en un paciente que la necesita, en particular un paciente apopléjico. Reivindicacion 15: Uso segun cualquiera de las reivindicaciones precedentes, en el cual la trombomodulina tiene una secuencia de aminoácido correspondiente a la secuencia de aminoácido de trombomodulina soluble madura y comprende una o más de las siguientes modificaciones: Eliminacion de aminoácidos 1-3, M388L, R456, H457Q, S474A, y terminando en P490.
ARP080102791A 2007-07-10 2008-06-27 Uso de trombomodulina para la preparacion de un medicamento trombolitico AR067345A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07013480A EP2014296A1 (en) 2007-07-10 2007-07-10 Novel strategies for increasing the reperfusion in obstructed blood vessel
EP08009096 2008-05-16
EP08010333 2008-06-06

Publications (1)

Publication Number Publication Date
AR067345A1 true AR067345A1 (es) 2009-10-07

Family

ID=40229136

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080102791A AR067345A1 (es) 2007-07-10 2008-06-27 Uso de trombomodulina para la preparacion de un medicamento trombolitico

Country Status (5)

Country Link
EP (1) EP2175872A2 (es)
JP (1) JP2010532776A (es)
AR (1) AR067345A1 (es)
CL (1) CL2008001977A1 (es)
WO (1) WO2009007112A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9592275B2 (en) 2011-11-15 2017-03-14 Asahi Kasei Pharma Corporation Medicament for therapeutic treatment and/or improvement of sepsis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU675422B2 (en) * 1992-02-05 1997-02-06 David Richard Light Protease-resistant thrombomodulin analogs
IL129877A (en) * 1996-11-27 2004-08-31 Aventis Pharm Prod Inc A pharmaceutical preparation containing a component having an Xa antagonist activity and an antifouling agent
US20010041686A1 (en) * 2000-01-06 2001-11-15 Veronique Mary Novel therapeutic application of enoxaparin
US20020111296A1 (en) * 2000-08-31 2002-08-15 Festoff Barry W. Thrombomodulin analogs for use in recovery of spinal cord injury
ATE304021T1 (de) * 2001-05-25 2005-09-15 Vlaams Interuniv Inst Biotech Lektin-ähnliche domäne von thrombomodulin und therapeutische verwendung davon
WO2002100445A1 (en) * 2001-06-13 2002-12-19 The University Of Sydney Treatment and composition for wound healing
WO2004096267A1 (de) * 2003-05-02 2004-11-11 Paion Gmbh Intravenöse injektion nicht-neurotoxischer plasminogen-aktivatoren zur behandlung von schlaganfall

Also Published As

Publication number Publication date
EP2175872A2 (en) 2010-04-21
JP2010532776A (ja) 2010-10-14
CL2008001977A1 (es) 2009-03-06
WO2009007112A4 (en) 2009-06-11
WO2009007112A3 (en) 2009-04-16
WO2009007112A2 (en) 2009-01-15

Similar Documents

Publication Publication Date Title
CY1124720T1 (el) Απο του στοματος σκευασματα αναλογων κυτιδινης και μεθοδοι χρησης αυτων
CY1119616T1 (el) Συζευγματα ανθρωπινου αντισωματος-φαρμακου κατα του ιστικου παραγοντα
BRPI0516830A (pt) composições de droga de liberação sustentada convenientemente implantáveis
AR049985A1 (es) Tratamiento de combinacion para enfermedades malignas no hematologicas
WO2008058547A3 (en) Alpha-lactalbumin composition
AR082579A2 (es) Una composicion farmaceutica espontaneamente dispersable para la administracion oral, uso para la preparacion de un medicamento para el tratamiento del cancer, metodo para incrementar los niveles de biodisponibilidad o reducir su variabilidad
CA2716874A1 (en) A pharmaceutical composition and its use in the preparation of a medicament for the treatment of cerebrovascular diseases
UA88464C2 (ru) Способ дермального введения метадоновой композиции с обеспечением системного действия
MXPA05011208A (es) Uso de ivermectina para el tratamiento de desordenes dermatologicos.
RS51213B (sr) Farmaceutski vaginalni gel koji sadrži tenofovir
WO2006076620A3 (en) Bendamustine pharmaceutical compositions for lyophilisation
ES2534303T3 (es) Procedimientos y composiciones que implican miARN y moléculas inhibidoras de miARN
EA200702522A1 (ru) Система доставки лекарств в полость рта и способы ее применения
MX2018006299A (es) Analogos de peptido de la hormona de estimulacion de alfa-melanocito.
BRPI0815578B8 (pt) Peptídeo de cdca1, seu uso e composição imunogênica compreendendo o mesmo para induzir imunidade, tratar e/ou prevenir o câncer, bem como método in vitro para induzir uma célula apresentadora de antígeno e uma célula t citotóxica (killer)
WO2015183995A3 (en) Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
CY1115961T1 (el) Ανυδρη μορφη κρυσταλλικης μηλεϊνικης ορβεπιταντης (orvepitant maleate)
ATE287267T1 (de) Kombinationstherapien mit gefässschädigender aktivität
BR112017022755A2 (pt) formulações de glucopiranosil lipídeo a e alérgeno a amendoim para administração sublingual
UA93365C2 (ru) Инъекционная форма диклофенака и его фармацевтически приемлемых солей (варианты) и способ его приготовления (варианты)
BRPI0416188A (pt) formulações de medicamentos que contêm aromatizante, com propriedades farmacêuticas aperfeiçoadas
AR067345A1 (es) Uso de trombomodulina para la preparacion de un medicamento trombolitico
WO2023104114A8 (en) Rna formulations and lipids
PA8624501A1 (es) Piperazinas derivadas de úrea para el tratamiento de la endometrosis
AR050937A1 (es) Composicion para administracion a traves de la mucosa y metodo para aumentar la absorcion a traves de la mucosa

Legal Events

Date Code Title Description
FB Suspension of granting procedure